Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Host-directed therapies against early-lineage SARS-CoV-2 ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
0
Authors
Ann‐Kathrin Reuschl
27 more
Ann‐Kathrin Reuschl
•
Jacqueline Fabius
25 more
•
Nevan Krogan
Published
February 4, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Microbiology
Medicine
Pathology
Genetics
Show all topics
DOI
10.1101/2021.01.24.427991
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Microbiology
Medicine
Pathology
Genetics
Show all topics
DOI
10.1101/2021.01.24.427991
License
CC-BY-NC-ND
Other Formats
PDF
